However, it should be noted that our present analysis demonstrated that DDR2 and collagen type I immunoreactivity was more frequently observed in the breast cancer tissues treated with neoadjuvant chemotherapy, while DDR2 contributed to breast cancer recurrence cooperatively with collagen type I and served as a strong prognostic factor, especially in those who received chemotherapy. The gene discussed is DDR2; the disease is breast cancer.